Viewing Study NCT04536792


Ignite Creation Date: 2025-12-24 @ 3:51 PM
Ignite Modification Date: 2025-12-27 @ 5:22 AM
Study NCT ID: NCT04536792
Status: COMPLETED
Last Update Posted: 2024-04-16
First Post: 2020-07-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-946 in Healthy Volunteers and in Participants With Sickle Cell Disease
Sponsor: Agios Pharmaceuticals, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy Volunteers View
None Anemia, Sickle Cell View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Sickle Cell Disease View
None Healthy View